First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead
Open Access
- 11 October 2011
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 14 (3) , 365-372
Abstract
Cardiac resynchronization therapy (CRT) is sometimes complicated by elevated pacing thresholds and phrenic nerve stimulation (PNS), both of which may require that the coronary sinus lead be repositioned. The purpose of this study was to evaluate the performance of a novel quadripolar electrode lead and cardiac resynchronization therapy-defibrillator (CRT-D) device that enables electrical repositioning, potentially obviating a lead reposition procedure. Patients indicated for CRT were enrolled and received a quadripolar electrode lead and CRT-D device (Quartet®model 1458Q and Promote Q®; St Jude Medical, Sylmar, CA, USA). Electrical data, and the presence of PNS during pacing from each left ventricular (LV) configuration, were documented at pre-hospital discharge and at 1 month. Seventy-five patients were enrolled and 71 were successfully implanted with a Quartet®lead. Electrical measurements were stable over the follow-up period. Ninety-seven per cent (64 of 66) of patients had one or more programmable configurations with a threshold <2.5 V and no PNS vs. 86% (57 of 66) if only conventional bipolar configurations were considered. Physicians were able to use the increased programming options to manage threshold changes and PNS. The new quadripolar electrode LV lead provides more programming options to address common problems faced when managing CRT patients. Electrical measurements from new vectors are comparable with conventional configurations. Furthermore, 11% of patients in the study suffered PNS on all conventional bipolar vectors.Keywords
This publication has 27 references indexed in Scilit:
- 2010 Focused Update of ESC Guidelines on device therapy in heart failureEP Europace, 2010
- Lead positioning for cardiac resynchronization therapy: techniques and prioritiesEP Europace, 2009
- Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure EventsNew England Journal of Medicine, 2009
- Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart FailureCirculation, 2009
- Cardiac resynchronization therapy implantation: a blend of skill and technologyEuropean Heart Journal Supplements, 2007
- Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm AssociationEP Europace, 2007
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Cardiac Resynchronization in Chronic Heart FailureNew England Journal of Medicine, 2002
- Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction DelayNew England Journal of Medicine, 2001
- Heart failure: a growing public health problemJournal of Internal Medicine, 1995